Stage-Dependent Role of Nitric Oxide in Control ofTrypanosoma cruziInfection
Open Access
- 1 April 2001
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 69 (4) , 2252-9
- https://doi.org/10.1128/iai.69.4.2252-2259.2001
Abstract
Trypanosoma cruzi, the causative agent of Chagas' disease, is known to be susceptible to nitric oxide (NO)-dependent killing by gamma interferon-activated macrophages. Mice deficient for inducible nitric oxide synthase (iNOS) are highly susceptible toT. cruzi, and inhibition of iNOS from the beginning of infection was reported to lead to an increase in trypomastigotes in the blood and to high mortality. In the present study, we investigated whether NO production is essential for the control ofT. cruziin all phases of the infection. BALB/c mice were treated at different time intervals afterT. cruziinfection with an iNOS inhibitor, aminoguanidine orl-N6-(1-iminoethyl)-lysine (L-NIL). Treatment initiated with the beginning of the infection resulted in 100% mortality by day 16 postinfection (p.i.). If treatment was started later during the acute phase at the peak of parasitemia (day 20 p.i.), all the mice survived. Parasitemia was cleared and tissue amastigotes became undetectable in these mice even in the presence of the iNOS inhibitor L-NIL. Inhibition of iNOS in the chronic phase of the infection, i.e., from day 60 to day 120 p.i., with L-NIL did not result in a reappearance of parasitemia. These data suggest that while NO is essential forT. cruzicontrol in the early phase of acute infection, it is dispensable in the late acute and chronic phase, revealing a fundamental difference in control mechanisms compared to those in infections by other members of the orderKinetoplastida, e.g.,Leishmania major.Keywords
This publication has 31 references indexed in Scilit:
- Effects of Interleukin-4 Deprivation and Treatment on Resistance toTrypanosoma cruziInfection and Immunity, 2000
- Chagas Disease Etiology: Autoimmunity or Parasite Persistence?Parasitology Today, 1999
- Trypanosoma cruzi is a potent inducer of interleukin-12 production in macrophagesMedical Microbiology and Immunology, 1996
- Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase.The Journal of Experimental Medicine, 1996
- Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and diseaseInternational Immunology, 1996
- Role of nitric oxide in resistance and histopathology during experimental infection with Trypanosoma cruziImmunology Letters, 1995
- Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8Immunology Letters, 1995
- Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.The Journal of Experimental Medicine, 1992
- Cloning and sequencing of a 24‐kDa Trypanosoma cruzi specific antigen released in association with membrane vesicles and defined by a monoclonal antibodyBiology of the Cell, 1992
- Endogenous Interferon- , Macrophage Activation, and Murine Host Defense against Acute Infection with Trypanosoma cruziThe Journal of Infectious Diseases, 1991